查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401003

四肢瘫痪治疗市场，按治疗类型、按给药途径、按配销通路、按国家和地区划分 - 2023-2030 年行业分析、市场规模、市场份额和预测

Quadriplegia Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 287 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年四肢瘫痪治疗市场规模为 14.684 亿美元，2023 年至 2030 年CAGR为 4.3%。

四肢瘫痪治疗市场-市场动态

神经假体和脑机介面（BCI）技术的快速发展推动市场需求

革命性的方法允许大脑和外部设备直接接触，为四肢瘫痪患者恢復肢体功能和运动带来希望。推动力是科学进步和患者对更多自由的不断增长的需求的结合。研究人员、神经科学家和公司正在大力投资开发更复杂的脑机介面和神经义肢，其动机是改善四肢瘫痪患者的生活品质并开闢神经復健的新领域，使以前难以想像的恢復水平成为现实。

四肢瘫痪治疗市场 - 主要见解

根据我们的研究分析师分享的分析，预计全球四肢瘫痪治疗市场在预测期内（2023-2030）每年将以 4.3% 左右的CAGR成长

由于神经假体和脑机介面（BCI）技术的快速发展，四肢瘫痪治疗产业预计将以显着的速度成长

根据治疗类型细分，预计皮质类固醇将在 2022 年显示最大的市场份额

根据给药途径细分，口服是 2022 年领先的治疗类型

按地区划分，亚太地区是 2022 年领先的收入来源

四肢瘫痪治疗市场-細項分析：

全球四肢瘫痪治疗市场根据治疗类型、给药途径、配销通路和区域进行细分。

根据治疗类型，市场分为六类：皮质类固醇、非类固醇抗发炎药、抗忧郁药、抗惊厥药、麻醉镇痛药、解痉药和肌肉鬆弛药。皮质类固醇在市场上占主导地位。四肢瘫痪治疗中皮质类固醇疗法供不应求。皮质类固醇因其抗发炎特性而被广泛用于治疗急性脊髓损伤，但其疗效甚微。其他治疗方法，包括物理治疗、辅助装置和神经復健程序，在提高四肢瘫痪患者的功能和生活品质方面发挥更大的作用。

根据给药途径，市场分为两类：口服、静脉注射。口腔产业在市场中占据主导地位，并可能在预测期内保持其主导地位。口服疗法很少用于四肢瘫痪治疗，因为它们无法成功解决这种疾病的根本原因，即脊髓损伤。物理治疗、辅助设备和更专业的治疗是主要的治疗重点，口服药物在四肢瘫痪的治疗中只占一小部分。

四肢瘫痪治疗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。有几个变数影响亚太地区四肢瘫痪治疗的需求。该地区人口规模较大，因事故等原因造成不同程度的脊髓损伤。此外，由于医疗基础设施的改善和专业復健服务的提供，人们对完全四肢瘫痪治疗的认识和需求不断增长。此外，辅助技术的进步，包括外骨骼和神经假体，作为提高该地区四肢瘫痪者生活品质的可行解决方案而受到关注。最后，人口老化可能会增加对有效疗法的需求，以解决与年龄相关的脊髓损伤和退化性疾病的影响。

四肢瘫痪治疗市场-竞争格局：

医疗保健提供者、復健中心、辅助科技製造商和研究机构构成了四肢瘫痪治疗的竞争环境。例如，ReWalk Robotics 和 Ekso Bionics 专门製造机器人外骨骼以改善运动。迈阿密治癒瘫痪计画和克里斯多福和达纳里夫基金会赞助开发四肢瘫痪疗法的研究。甘乃迪克里格研究所等復健中心提供综合治疗和治疗。这些参与者之间正在该领域合作，开发神经修復术和再生医学等创新疗法，目标是改善四肢瘫痪患者的独立性和康復能力，并扩大这一专业医疗保健领域的可用选择。

目录

第一章：四肢瘫痪治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 四肢瘫痪治疗市场片段（依治疗类型）
    • 四肢瘫痪治疗市场片段（依给药途径）
    • 四肢瘫痪治疗市场片段（按配销通路）
    • 四肢瘫痪治疗市场片段（按国家/地区）
    • 按地区分類的四肢瘫痪治疗市场片段
  • 竞争洞察

第 3 章：四肢瘫痪治疗主要市场趋势

  • 四肢瘫痪治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 四肢瘫痪治疗市场限制
    • 市场限制影响分析
  • 四肢瘫痪治疗市场机会
  • 四肢瘫痪治疗市场未来趋势

第 4 章：四肢瘫痪治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：四肢瘫痪治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：四肢瘫痪治疗市场模式

  • 2022 年四肢瘫痪治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：四肢瘫痪治疗市场 - 按治疗类型

  • 概述
    • 按治疗类型分類的细分市场份额分析
    • 皮质类固醇
    • 非类固醇抗发炎药
    • 抗忧郁药
    • 抗惊厥药
    • 麻醉镇痛药
    • 解痉药和肌肉鬆弛药

第 8 章：四肢瘫痪治疗市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市占率分析
    • 口服
    • 静脉

第 9 章：四肢瘫痪治疗市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 医院
    • 药局
    • 零售药局
    • 药局
    • 网上商店

第 10 章：四肢瘫痪治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美四肢瘫痪治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按治疗类型）
    • 北美市场规模与预测（按管理途径）
    • 北美市场规模和预测（按配销通路）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲四肢瘫痪治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按治疗类型）
    • 欧洲市场规模与预测（按管理途径）
    • 欧洲市场规模和预测（按配销通路）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区四肢瘫痪治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按治疗类型）
    • 亚太地区市场规模与预测（依管理途径）
    • 亚太地区市场规模和预测（按配销通路）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲四肢瘫痪治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按治疗类型）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 拉丁美洲市场规模和预测（按配销通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲四肢瘫痪治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按治疗类型）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模及预测（按配销通路）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 四肢瘫痪治疗产业

  • 竞争仪表板
  • 公司简介
    • ReWalk Robotics
    • Ekso Bionics
    • Cyberdyne Inc.
    • Invacare Corporation
    • Hocoma AG
    • Axogen Corporation
    • Myomo Inc.
    • Ossur
    • Parker Hannifin
    • InVivo Therapeutics
    • University of California, Los Angeles (UCLA)
    • The Miami Project to Cure Paralysis
    • Kennedy Krieger Institute
    • Cleveland Clinic
    • Swiss Paraplegic Centre

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1967

REPORT HIGHLIGHT

Quadriplegia Treatment Market size was valued at USD 1,468.4 Million in 2022, expanding at a CAGR of 4.3 % from 2023 to 2030.

Quadriplegia therapy is a complex strategy to address the physical and functional restrictions caused by severe spinal cord injuries, which normally affect all four limbs and often end in considerable paralysis. While comprehensive treatments are presently unattainable, quadriplegia therapy focuses on improving afflicted persons' quality of life and independence. This encompasses physical therapy, assistive devices, mobility aids, and sophisticated technology including exoskeletons and neuroprosthetics. In addition, continuing research looks at regenerative medicine, brain interfaces, and other novel therapies to help quadriplegics regain function and autonomy.

Quadriplegia Treatment Market- Market Dynamics

Rapid development of neuroprosthetic and brain-computer interface (BCI) technologies propel market demand

Revolutionary methods allow direct contact between the brain and external equipment, providing hope for quadriplegics to regain limb function and movement. The driving force is a combination of scientific advancements and growing demand from patients desiring more freedom. Researchers, neuroscientists, and companies are investing heavily in the development of more sophisticated BCIs and neuroprosthetics, motivated by the desire to improve the quality of life for quadriplegics and open up new frontiers in neural rehabilitation, allowing previously unimaginable levels of restoration to become a reality.

Quadriplegia Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global Quadriplegia Treatment market is estimated to grow annually at a CAGR of around 4.3% over the forecast period (2023-2030)

The Quadriplegia Treatment industry is projected to grow at a significant rate due to rapid development of neuroprosthetic and brain-computer interface (BCI) technologies

Based on Treatment Type segmentation, Corticosteroids was predicted to show maximum market share in the year 2022

Based on Route of Administration segmentation, Oral was the leading Treatment Type in 2022

On the basis of region, Asia Pacific was the leading revenue generator in 2022

Quadriplegia Treatment Market- Segmentation Analysis:

The Global Quadriplegia Treatment Market is segmented on the basis of Treatment Type, Route of Administration, Distribution Channel, and Region.

The market is divided into six categories based on Treatment Type: Corticosteroids, Non- Steroidal Anti-inflammatory Drugs, Antidepressants, Anticonvulsants, Narcotic Analgesics, Antispasmodics & Muscle Relaxants. The Corticosteroids dominates the market. Corticosteroid therapies are in short supply in quadriplegia therapy. Corticosteroids are largely utilized for their anti-inflammatory qualities in the treatment of acute spinal cord injuries, however they have demonstrated minimal efficacy. Other treatment methods, including as physical therapy, assistive devices, and neurorehabilitation procedures, play a larger role in increasing quadriplegic people' function and quality of life.

The market is divided into two categories based on Route of Administration: Oral, Intravenous. The Oral sector dominates the market and is likely to maintain its dominance during the forecast period. Oral therapies are seldom used in quadriplegia therapy because they are unsuccessful in addressing the underlying causes of this disorder, which are spinal cord injuries. Physical therapy, assistive devices, and more specialized therapies are the primary treatment focuses, with oral drugs having a minor part in quadriplegia management.

Quadriplegia Treatment Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several variables impact the need for quadriplegia therapy in the Asia-Pacific area. The region has a sizable population with varied degrees of spinal cord injury caused by accidents and other reasons. Furthermore, growing awareness and demand for complete quadriplegia therapy have resulted from improved healthcare infrastructure and the availability of specialized rehabilitation services. Additionally, advances in assistive technology, including as exoskeletons and neuroprosthetics, are gaining traction as viable solutions to enhance the quality of life for quadriplegic people in the area. Finally, an aging population may increase the need for effective therapies to address the effects of age-related spinal cord injuries and degenerative disorders.

Quadriplegia Treatment Market- Competitive Landscape:

Healthcare providers, rehabilitation centers, assistive technology manufacturers, and research organizations make up the competitive environment in quadriplegia therapy. ReWalk Robotics and Ekso Bionics, for example, specialize in building robotic exoskeletons to improve movement. The Miami Project to Cure Paralysis and the Christopher and Dana Reeve Foundation sponsor research to develop quadriplegia therapies. Comprehensive treatment and therapy are provided by rehabilitation centers such as the Kennedy Krieger Institute. Collaboration between these players is taking place in the field to develop innovative treatments, such as neuroprosthetics and regenerative medicine, with the goal of improving independence and rehabilitation for quadriplegic individuals and expanding the range of available options in this specialized healthcare domain.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL QUADRIPLEGIA TREATMENT MARKET KEY PLAYERS

  • ReWalk Robotics
  • Ekso Bionics
  • Cyberdyne Inc.
  • Invacare Corporation
  • Hocoma AG
  • Axogen Corporation
  • Myomo Inc.
  • Ossur
  • Parker Hannifin
  • InVivo Therapeutics
  • University of California, Los Angeles (UCLA)
  • The Miami Project to Cure Paralysis
  • Kennedy Krieger Institute
  • Cleveland Clinic
  • Swiss Paraplegic Centre

GLOBAL QUADRIPLEGIA TREATMENT MARKET, BY TREATMENT TYPE

  • Corticosteroids
  • Non- Steroidal Anti-inflammatory Drugs
  • Antidepressants
  • Anticonvulsants
  • Narcotic Analgesics
  • Antispasmodics & Muscle Relaxants

GLOBAL QUADRIPLEGIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Intravenous

GLOBAL QUADRIPLEGIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL

  • Hospital
  • Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores

GLOBAL QUADRIPLEGIA TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Quadriplegia Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Quadriplegia Treatment Market Snippet by Treatment Type
    • 2.1.2. Quadriplegia Treatment Market Snippet by Route of Administration
    • 2.1.3. Quadriplegia Treatment Market Snippet by Distribution Channel
    • 2.1.4. Quadriplegia Treatment Market Snippet by Country
    • 2.1.5. Quadriplegia Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Quadriplegia Treatment Key Market Trends

  • 3.1. Quadriplegia Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Quadriplegia Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Quadriplegia Treatment Market Opportunities
  • 3.4. Quadriplegia Treatment Market Future Trends

4. Quadriplegia Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Quadriplegia Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Quadriplegia Treatment Market Landscape

  • 6.1. Quadriplegia Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Quadriplegia Treatment Market - By Treatment Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
    • 7.1.2. Corticosteroids
    • 7.1.3. Non- Steroidal Anti-inflammatory Drugs
    • 7.1.4. Antidepressants
    • 7.1.5. Anticonvulsants
    • 7.1.6. Narcotic Analgesics
    • 7.1.7. Antispasmodics & Muscle Relaxants

8. Quadriplegia Treatment Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Intravenous

9. Quadriplegia Treatment Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Hospital
    • 9.1.3. Pharmacies
    • 9.1.4. Retail Pharmacies
    • 9.1.5. Drug Stores
    • 9.1.6. Online Stores

10. Quadriplegia Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Quadriplegia Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Quadriplegia Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Quadriplegia Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Quadriplegia Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Quadriplegia Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Quadriplegia Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. ReWalk Robotics
    • 11.2.2. Ekso Bionics
    • 11.2.3. Cyberdyne Inc.
    • 11.2.4. Invacare Corporation
    • 11.2.5. Hocoma AG
    • 11.2.6. Axogen Corporation
    • 11.2.7. Myomo Inc.
    • 11.2.8. Ossur
    • 11.2.9. Parker Hannifin
    • 11.2.10. InVivo Therapeutics
    • 11.2.11. University of California, Los Angeles (UCLA)
    • 11.2.12. The Miami Project to Cure Paralysis
    • 11.2.13. Kennedy Krieger Institute
    • 11.2.14. Cleveland Clinic
    • 11.2.15. Swiss Paraplegic Centre

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Route of Administrations
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Quadriplegia Treatment Market: Treatment Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment Type
  • TABLE Global Quadriplegia Treatment Market, by Treatment Type 2018-2030 (USD Million)
  • TABLE Quadriplegia Treatment Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Quadriplegia Treatment Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Quadriplegia Treatment Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Quadriplegia Treatment Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Quadriplegia Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Quadriplegia Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Quadriplegia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Quadriplegia Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE North America Quadriplegia Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Quadriplegia Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Quadriplegia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Quadriplegia Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Europe Quadriplegia Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Quadriplegia Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Quadriplegia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Quadriplegia Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Quadriplegia Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Quadriplegia Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Quadriplegia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Quadriplegia Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Latin America Quadriplegia Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Quadriplegia Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Quadriplegia Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Quadriplegia Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Quadriplegia Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Quadriplegia Treatment Market, by Distribution Channel, 2018-2030 (USD Million)